Covered recipient · General Payments record
JA-YOON U CHOE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2025
$1,426.01
- Reported across 40 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $899.62 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $199.77 | 4 |
| Gilead Sciences, Inc. | $199.15 | 4 |
| ABBVIE INC. | $168.61 | 6 |
| Calyxo, Inc. | $128.89 | 1 |
| Novo Nordisk AS | $119.94 | 1 |
| Lilly USA, LLC | $83.26 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.97 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655450 | CMS |
| ABBVIE INC. | $26.37 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655452 | CMS |
| ABBVIE INC. | $31.14 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655454 | CMS |
| ABBVIE INC. | $28.67 | 06/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655456 | CMS |
| ABBVIE INC. | $26.19 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655458 | CMS |
| ABBVIE INC. | $25.27 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201655460 | CMS |
| Aimmune Therapeutics, Inc. | $26.79 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249706225 | CMS |
| Aimmune Therapeutics, Inc. | $31.43 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249706229 | CMS |
| Aimmune Therapeutics, Inc. | $111.65 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249716281 | CMS |
| Aimmune Therapeutics, Inc. | $29.90 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249706227 | CMS |
| Calyxo, Inc. | $128.89 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246160437 | CMS |
| Gilead Sciences, Inc. | $125.00 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234382561 | CMS |
| Gilead Sciences, Inc. | $18.54 | 07/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234543757 | CMS |
| Gilead Sciences, Inc. | $32.17 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234427454 | CMS |
| Gilead Sciences, Inc. | $23.44 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234490094 | CMS |
| Lilly USA, LLC | $29.67 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186696633 | CMS |
| Lilly USA, LLC | $28.10 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186696635 | CMS |
| Lilly USA, LLC | $25.49 | 08/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186691153 | CMS |
| Novo Nordisk Inc | $119.94 | 03/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189086974 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.